表紙
市場調查報告書
商品編碼
1066295

進行的體外診斷 (IVD) 測試次數(2021-2026 年)

IVD Procedure Volumes 2021-2026

出版日期: | 出版商: Kalorama Information | 英文 | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告分析了全球體外診斷 (IVD) 檢測的實施情況,並預測了整體市場趨勢(檢測數量、銷售價格等)、細分市場和地區以及主要公司的詳細趨勢。我們將向您發送個人資料和產品銷售趨勢等信息。

目錄

第 1 章執行摘要

第二章介紹

第三章醫學趨勢

  • 概覽
  • 人口趨勢
  • 世界人口與老齡化
  • 勞動力減少
  • 應對老齡化趨勢
  • 新興市場和發達市場

第 4 章體外診斷 (IVD) 測試的細分

  • 體外診斷檢查趨勢
  • 分部增長預測
  • POC檢查
  • 臨床化學
  • 免疫測試
  • 質譜(免疫)
  • 分子檢測
  • 驗血
  • 凝血試驗
  • 常規微生物檢測
  • 血型檢測
  • 組織/細胞測試

第 5 章全球體外診斷 (IVD) 市場

  • 一般
  • 北美
  • 美國
  • 加拿大
  • 墨西哥/拉丁美洲
  • 巴西
  • 墨西哥
  • 其他拉丁美洲國家
  • 阿根廷
  • 哥倫比亞
  • 智利
  • 秘魯
  • 委內瑞拉
  • 所有其他國家/地區
  • 西歐
  • 法國
  • 德國
  • 意大利
  • 西班牙
  • 英國
  • 其他西歐國家
  • 荷蘭
  • 比利時
  • 奧地利
  • 瑞典
  • 瑞士
  • 丹麥
  • 葡萄牙
  • 挪威
  • 希臘
  • 愛爾蘭
  • 芬蘭
  • 所有其他國家/地區
  • 東歐
  • 俄羅斯
  • 其他東歐
  • 波蘭
  • 羅馬尼亞
  • 捷克共和國
  • 烏克蘭
  • 匈牙利
  • 所有其他國家
  • 亞太地區
  • 中國
  • 日本
  • 其他國家/地區
  • 印度
  • 韓國
  • 澳大利亞
  • 台灣
  • 越南
  • 巴基斯坦
  • 泰國
  • 馬來西亞
  • 印度尼西亞
  • 香港
  • 菲律賓
  • 新加坡
  • 新西蘭
  • 所有其他國家和地區
  • 中東
  • 土耳其
  • 其他中東國家
  • 伊朗
  • 沙特阿拉伯
  • 伊拉克
  • 以色列
  • 阿拉伯聯合酋長國
  • 所有其他國家
  • 非洲
  • 埃及
  • 南非
  • 尼日利亞
  • 所有其他國家和地區

第 6 章護理點 (POC) 治療

  • 全球 POC 治療數量:按測試類型
  • POC自查
  • 傳統血糖監測活動
  • 連續血糖監測
  • 懷孕/生育測試
  • 凝血試驗
  • 糞便潛血試驗
  • 藥物濫用測試
  • 幽門螺桿菌檢測
  • 艾滋病毒檢測
  • 傳染病
  • 膽固醇測試
  • POC 尿液分析
  • 其他POC自查
  • POC自檢產品銷售
  • 價格趨勢
  • POC 概念證明
  • POC專業血糖檢測流程
  • POC 概念驗證緊急醫療測試
  • POC生育力測試
  • POC 概念驗證傳染病測試
  • POC 概念驗證心臟標誌物測試
  • POC 概念驗證膽固醇/脂質測試
  • POC專業凝血檢測
  • POC 概念驗證 HbA1C 測試
  • POC專業驗血
  • POC專業大便潛血檢測
  • POC 概念證明藥物濫用測試
  • POC專業驗尿
  • 其他 POC 概念驗證
  • POC IVD產品銷售
  • 價格趨勢

第7章臨床化學

  • 檢查類型
  • 普通化學
  • 葡萄糖
  • 脂質
  • 蛋白質
  • 其他化合物
  • 血氣/電解質
  • 尿液分析
  • 全球臨床化學產品銷售
  • 價格趨勢

第8章免疫分析治療

  • 技術
  • 標註方式
  • □免疫法
  • 熒光偏振免疫分析法 (FPIA)
  • 放射免疫分析(RIA)
  • 檢驗程序和產品銷售
  • 心形標記
  • 腫瘤標誌物
  • 自身免疫性疾病
  • 過敏症狀
  • 甲狀腺疾病
  • 蛋白質
  • 貧血
  • 生育力測試
  • 治療藥物監測
  • 維生素D
  • 糖尿病/HbA1c
  • 濫用物質
  • 傳染病
  • 設備
  • 價格趨勢

第9章分子測試程序

  • 檢查類型
  • 檢測技術
  • 傳染病
  • 血液篩查
  • 癌症
  • 端口匹配
  • 易栓症 SNP
  • 遺傳性疾病
  • 其他分子檢測
  • 出生前
  • 全球分子IVD產品銷售
  • 價格趨勢

第 10 章基於實驗室的血液檢測程序

  • 檢查類型
  • 全球血液檢測產品銷售
  • 價格趨勢

第11章凝血試驗程序

  • 檢查類型
  • 全球凝血檢測產品銷售
  • 價格趨勢

第12章微生物檢測程序

  • 檢查類型
  • ID/AST自動面板/試劑
  • 手動面板/試劑
  • 血培養
  • 顯色介質
  • 快速微生物檢測
  • 質譜
  • 常規體外診斷微生物產品的全球銷售
  • ID/AST panel/試劑
  • 血培養
  • 顯色介質
  • 快速微生物檢測
  • 質譜
  • 價格趨勢

第13章血型分型程序

  • 檢查類型
  • 銷售血型檢測產品
  • 價格趨勢

第 14 章組織/細胞檢查程序

  • 檢查類型
  • 巴氏試驗
  • 原位雜交試驗
  • 免疫組化檢查
  • 常規非巴氏染色
  • 循環腫瘤細胞
  • 流式細胞儀檢測
  • Omics/Cell IVD產品銷售
  • 價格趨勢

第 15 章公司簡介

  • Abbott Laboratories
  • Agilent Technologies
  • Becton, Dickinson and Company (BD)
  • bioMérieux Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Dexcom
  • DiaSorin
  • Exact Sciences
  • Hologic, Inc.
  • Illumina
  • Ortho Clinical Diagnostics (Ortho)
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Roche
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Werfen
目錄
Product Code: 22-025

In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama Information's “ IVD Test Procedure Volumes, 2021-2026 ” saves time with calculations and estimates of both the existing number of procedures for scores of diagnostic tests, and the future potential. In the process, pricing analysis is also performed. This report is an essential resource for the IVD business planner.

The report estimates IVD test procedure volume and IVD pricing for the following segments:

  • Worldwide IVD Market and Test Volume
  • Point-of-Care (POC) Market and Test Volume
  • Clinical Chemistry Market and Test Volume
  • Molecular Market and Test Volume
  • Hematology Market and Test Volume
  • Coagulation Market and Test Volume
  • Microbiology Market and Test Volume
  • Blood Banking Market and Test Volume
  • COVID-19 Market and Test Volume
  • Histology/Cytology Market and Test Volume
  • Immunoassay Market and Test Volume
  • IVD Testing Segments and Global IVD Markets

“ IVD Test Procedure Volumes, 2021-2026 ” includes profiles of the top IVD market competitors, looking in detail where possible at procedural volume by type. The companies covered are the following:

  • Abbott Laboratories
  • Agilent Technologies
  • Becton, Dickinson and Company (BD)
  • bioMérieux Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Dexcom
  • DiaSorin
  • Exact Sciences
  • Hologic, Inc.
  • Illumina
  • Ortho Clinical Diagnostics (Ortho)
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Roche
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Werfen

Table of Contents

Chapter One: Executive Summary

  • Figure 1-1: Global IVD Procedure Volumes, 2021 and 2026, (in millions $)
  • IVD Procedure Volume Estimate and Forecast
  • Scope & Methodology
  • About Kalorama Information

Chapter Two: Introduction

  • Industry Trends
    • Table 2-1: Global IVD Procedural Volume & Product Sales (includes glucose tests), 2021-2026
  • COVID 19

Chapter Three: Healthcare Trends

  • Overview
  • Demographic Trends
  • Global Population and Aging
    • Table 3-1: Elderly Support Ratio in Various Countries (Australia; Brazil; Canada; China; China, Hong Kong SAR; France; Germany; India; Italy; Japan; Mexico; Saudi Arabia; Singapore; South Africa; Spain; Turkey; United Kingdom; United States; World)
  • Workforce Reduction
    • Table 3-2: Age Under 15 and Over 65, by Continent (Africa, L. America/Caribbean, Asia, Oceania, N. America, Europe, World) 2020
  • Addressing the Aging Trend
  • Emerging and Emerged Markets
    • Table 3-3: Market Potential by Total Population, and Percent Urban 2021 (China, India, United States, Brazil, Russia, Mexico, Nigeria, Turkey, S. Korea, S. Africa, Vietnam, Poland, Saudi Arabia, Canada, Colombia, Ukraine, Egypt, Malaysia)

Chapter Four: IVD Testing Segments

  • IVD Testing Trends
    • Table 4-1: IVD Procedural Volume including blood glucose tests (millions), 2021-2026
    • Table 4-2: IVD Procedural Volume excluding blood glucose tests (millions), 2021-2026
  • Segment Growth Projections
  • POC Testing
  • Clinical Chemistry
  • Immunoassays
  • Mass Spectrometry (Immuno)
  • Molecular Assays
  • Hematology
  • Coagulation
  • Conventional Microbiology
  • Blood Grouping/Typing
  • Histology/Cytology
    • Table 4-3: IVD Product Sales including blood glucose tests ($ millions), 2021-2026
    • Table 4-4 IVD Product Sales excluding blood glucose tests ($ millions), 2021-2026

Chapter Five: Global IVD Markets

  • General
    • Table 5-1: IVD Procedural Volume excluding blood glucose tests by Region (millions), 2021-2026
    • Table 5-2: IVD Product Sales excluding blood glucose tests by Region ($ millions), 2021-2026
  • North America
  • United States
  • Canada
  • Mexico, Central & South America
  • Brazil
  • Mexico
  • Other Central & South America
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Venezuela
  • All Other Countries & Territories
  • Western Europe
  • France
  • Germany
  • Italy
  • Spain
  • United Kingdom
  • Other Western Europe
  • Netherlands
  • Belgium
  • Austria
  • Sweden
  • Switzerland
  • Denmark
  • Portugal
  • Norway
  • Greece
  • Ireland
  • Finland
  • All Other Countries & Territories
  • Eastern Europe
  • Russia
  • Other Eastern Europe
  • Poland
  • Romania
  • Czech Republic
  • Ukraine
  • Hungary
  • All Other Countries
  • Asia/Pacific
  • China
  • Japan
  • Other Asian Countries and Territories
  • India
  • South Korea
  • Australia
  • Taiwan
  • Vietnam
  • Pakistan
  • Thailand
  • Malaysia
  • Indonesia
  • Hong Kong
  • Philippines
  • Singapore
  • New Zealand
  • All Other Countries & Territories
  • Middle East
  • Turkey
  • Other Middle East
  • Iran
  • Saudi Arabia
  • Iraq
  • Israel
  • United Arab Emirates
  • All Other Countries
  • Africa
  • Egypt
  • South Africa
  • Nigeria
  • All Other Countries & Territories

Chapter Six: Point-of-Care (POC) Procedures

  • Global POC Procedure Volume by Test Type
    • Table 6-1: Total POC Procedural Volume & Product Sales including blood glucose tests, 2021-2026
    • Table 6-2: Total POC Procedural Volume & Product Sales excluding blood glucose tests, 2021-2026
    • Figure 6-1: US/ROW POC Procedure Volumes excluding blood glucose tests by Percent 2026
    • Figure 6-2: US/ROW POC Sales excluding blood glucose sales by Percent 2026
  • POC Self Tests
    • Table 6-3: POC Self-Test Procedural Volume by Type (millions), 2021-2026
  • Traditional Blood Glucose Monitoring Activities
  • Continuous Blood Glucose Monitoring
  • Pregnancy and Fertility Testing
  • Coagulation Testing
  • Fecal Occult Blood Testing
  • Drugs of Abuse Testing
  • Pylori Testing
  • HIV Testing
  • Infectious Disease
  • Cholesterol Testing
  • POC Urinalysis Testing
  • Other POC Self-Testing
  • POC Self-Testing Product Sales
    • Table 6-4: POC Self-Test Product Sales by Type ($ millions), 2021-2026
  • Pricing Trends
    • Table 6-5: POC Self-Test $ IVD Product Sales Per Procedure, 2021-2026
  • POC Professional Testing
    • Table 6-6: POC Professional Procedural Volume by Type (millions), 2021-2026
  • POC Professional Blood Glucose Testing Procedures
  • POC Professional Critical Care Testing
  • POC Fertility Testing
  • POC Professional Infectious Disease Testing
  • POC Professional Cardiac Marker Testing
  • POC Professional Cholesterol/Lipid Testing
  • POC Professional Coagulation Testing
  • POC Professional HbA1C Testing
  • POC Professional Hematology Testing
  • POC Professional Fecal Occult Blood Screening
  • POC Professional Drugs of Abuse Testing
  • POC Professional Urinalysis Testing
  • Other POC Professional Testing
  • POC IVD Product Sales
    • Table 6-7: POC Professional IVD Product Sales by Type ($ millions), 2021-2026
  • Pricing Trends
    • Table 6-8: POC Professional $ IVD Products Per Procedure by Type (millions), 2021-2026

Chapter Seven: Clinical Chemistry Procedures

  • Table 7-1: Clinical Chemistry Procedural Volume by Type (millions), 2021-2026
  • Figure 7-1: US/ROW Clinical Chemistry Procedure Volumes by Percent 2026
  • Types of Tests
  • General Chemistry
  • Enzymes
  • Glucose
  • Lipids
  • Proteins
  • Other Compounds
  • Blood Gases & Electrolytes
  • Urinalysis
  • Global Sales of Clinical Chemistry Products
    • Table 7-2: Clinical Chemistry Product Sales by Type ($ millions), 2021-2026
    • Figure 7-2: US/ROW Clinical Chemistry Sales by Percent 2026
  • Pricing Trends
    • Table 7-3: Clinical Chemistry $ IVD Product Sales Per Procedure ($), 2021-2026

Chapter Eight: Immunoassay Procedures

  • Technologies
  • Labeling Techniques
  • Enzyme Immunoassays
  • Fluorescence Polarization Immunoassays (FPIAs)
  • Radioimmunoassays (RIAs)
    • Table 8-1: Immunoassay Procedural Volume by Type (millions), 2021-2026
    • Figure 8-1: US/ROW Immunoassay Procedure Volumes by Percent 2026
  • Testing Procedures & Product Sales
    • Table 8-2: Immunoassay Product Sales by Type (millions), 2021-2026
    • Figure 8-2: US/ROW Immunoassay Sales by Percent 2026
  • Cardiac Markers
  • Tumor Markers
  • Autoimmune Conditions
  • Allergy Conditions
  • Thyroid Conditions
  • Proteins
  • Anemia
  • Fertility Testing
  • Therapeutic Drug Monitoring
  • Vitamin D
  • Diabetes/HbA1c
  • Drugs of Abuse
  • Infectious Diseases
    • Table 8-3: Immunoassay Infectious Disease exc Blood Screening Immuno Procedural Volume by Type (millions), 2021-2026
    • Table 8-4: Immunoassay Infectious Disease exc Blood Screening Immuno Product Sales by Type ($ millions), 2021-2026
  • Instruments
  • Pricing Trends
    • Table 8-5: Immunoassay $ Product Sales Per Procedure by Type, 2021-2026

Chapter Nine: Molecular Testing Procedures

  • Table 9-1: Molecular Assay Procedural Volume by Type (millions), 2021-2026
  • Figure 9-1: US/ROW Molecular Assay Procedure Volumes by Percent 2026
  • Types of Test
  • Testing Technologies
  • Infectious Diseases
    • Table 9-2: Molecular Assay Infectious Disease Procedural Volume by Type (millions), 2021-2026
  • Blood Screening
  • Cancer
  • Transplant Matching
  • Thrombophilia SNPs
  • Inherited Diseases
  • Other Molecular Tests
  • Prenatal
  • Global Sales of Molecular IVD Products
    • Table 9-3: Molecular Assay Product Sales by Type ($ millions), 2021-2026
    • Figure 9-2 : US/ROW Molecular Assay Sales by Percent 2026
    • Table 9-4: Molecular Assay Infectious Disease Product Sales by Type ($ millions), 2021-2026
  • Pricing Trends
    • Table 9-5: Molecular Assays $ Products per Procedure by Type, 2021-2026

Chapter Ten: Laboratory-Based Hematology Procedures

  • Table 10-1: Laboratory-Based Hematology Procedural Volume by Type (millions), 2021-2026
  • Figure 10-1: US/ROW Laboratory-Based Hematology Procedure Volumes by Percent 2026
  • Types of Tests
  • Global Sales of Hematology Products
    • Table 10-2: Laboratory-Based Hematology Product Sales by Type ($ millions), 2021-2006
    • Figure 10-2: US/ROW Hematology Sales by Percent 2026
  • Pricing Trends
    • Table 10-3: Hematology $ Product Sales Per Procedure by Type, 2021-2026

Chapter Eleven: Coagulation Testing Procedures

  • Table 11-1: Coagulation Procedural Volume (millions), 2021-2026
  • Figure11-1: US/ROW Coagulation Procedure Volumes by Percent 2026
  • Types of Tests
  • Global Sales of Coagulation Products
    • Table 11-2: Coagulation Product Sales ($ millions), 2021-2026
    • Figure 11-2: US/ROW Coagulation Sales by Percent 2026
  • Pricing Trends
    • Table 11-3: Coagulation $ Products per Procedure, 2021-2026

Chapter Twelve: Microbiology Procedures

  • Table 12-1: Conventional Microbiology Procedural Volume by Type (millions), 2021-2026
  • Figure 12-1: US/ROW Microbiology Procedure Volumes by Percent 2026
  • Types of Tests
  • ID/AST Automated Panels & Reagents
  • Manual Panels & Reagents
  • Blood Culture
  • Chromogenic Media
  • Rapid Microbiological Tests
  • Mass Spectrometry
  • Global Sales of Conventional IVD Microbiology Products
  • ID/AST Panels & Reagents
  • Blood Culture
  • Chromogenic Media
  • Rapid Microbiological Tests
  • Mass Spectrometry
    • Table 12-2: Conventional Microbiology Product Sales by Type ($ millions), 2021-2026
    • Figure 12-2: US/ROW Microbiology Sales by Percent 2026
  • Pricing Trends
    • Table 12-3: Conventional Microbiology $ Product Sales Per Procedures by Type, 2021-2026

Chapter Thirteen: Blood Grouping/Typing Procedures

  • Table 13-1: Blood Grouping/Typing Procedure Volumes ($ millions), 2021-2026
  • Figure 13-1: US/ROW Blood Grouping/Typing Procedure Volumes by Percent 2026
  • Types of Tests
  • Blood Grouping/Typing Product Sales
    • Table 13-2: Blood Grouping/Typing Product Sales ($ millions), 2021-2026
    • Figure 13-2: US/ROW Blood Grouping/Typing Sales by Percent 2026
  • Pricing Trends
    • Table 13-3: Blood Grouping/Matching $ Product Sales/Procedure, 2021-2026

Chapter Fourteen: Histology/Cytology Procedures

  • Table 14-1: Histology/Cytology Procedural Volume by Type (millions), 2021-2026
  • Figure 14-1: US/ROW Histology/Cytology Procedure Volumes by Percent 2026
  • Types of Tests
  • Pap Tests
  • In Situ Hybridization Tests
  • Immunohistochemistry Tests
  • Traditional Non-Pap Stains
  • Circulating Tumor Cells
  • Flow Cytometry
  • Histology/Cytology IVD Product Sales
    • Table 14-2: Histology/Cytology Product Sales by Type ($ millions), 2021-2026
    • Figure 14-2: US/ROW Histology/Cytology Sales by Percent 2026
  • Pricing Trends
    • Table 14-3: Histology/Cytology $ Product Sales Per Procedure by Type, 2021-2026

Chapter Fifteen: Company Profiles

  • Table 15-1: Revenues of Selected Top 19 IVD Companies, 2017-2021 ($ million)
  • Abbott Diagnostics
  • Recent Revenue History
    • Table 15-2: Abbott Diagnostic Revenues 2017-2021 (millions $)
  • Alere Acquisition Update and Point of Care
  • Core Lab
  • Hematology
  • Blood Banking
  • Infectious Diseases - Molecular
  • Diabetes
  • HIV Point of Care
  • i-STAT Business
  • Agilent Technologies
  • Recent Revenue History
    • Table 15-3: Agilent Revenues 2017-20121 (millions $)
  • Agilent in Genomics
  • Cytogenetic Analysis
  • Sequencing
  • Flow Cytometry
  • Companion Diagnostics - Dako
  • COVID-19
  • Becton, Dickinson and Company (BD)
  • Recent Revenue History
    • Table 15-4: BD Diagnostic Revenues 2017-2021 (millions $)
  • Cytology
  • Molecular Microbiology
  • Traditional Microbiology - ID/AST
  • Blood Culture
  • Hospital Acquired Infections
  • Blood Collection
  • Mass Spectrometry
  • Flow Cytometry
  • COVID-19
  • bioMérieux Inc.
  • Recent Revenue History
    • Table 15-5: bioMérieux IVD Revenues 2017-2021 (millions $)
  • Traditional Microbiology
  • Blood Culture
  • Immunoassays
  • Mass Spectrometry
  • BioFire Diagnostics Business
  • COVID-19
  • Bio-Rad Laboratories, Inc.
  • Recent Revenue History
    • Table 15-6: Bio-Rad Diagnostics Revenues 2017-2021 (millions $)
  • Blood Bank
  • Immunoassays
  • Danaher Corporation
    • Table 15-7: Danaher Global IVD Diagnostic Sales, 2017-2021 ($million)
  • Dexcom
  • Recent Revenue History
    • Table 15-8: Dexcom IVD Diagnostic Sales, 2017-2021 ($million)
  • DiaSorin
  • Recent Revenue History
    • Table 15-9: DiaSorin Revenues 2017-2021 (millions $)
  • Immunoassays
  • Molecular
  • COVID-19
  • Exact Sciences
  • Recent Revenue History
    • Table 15-10: Exact Sciences Revenues 2017-2021 (millions $)
  • COVID-19
  • Hologic, Inc.
  • Recent Revenue History
    • Table 15-11: Hologic Revenues 2017-2021 (millions $)
  • PANTHER Molecular System
  • HIV Testing
  • Sexually Transmitted Infections
  • Infectious Diseases
  • Cytology
  • COVID-19
  • Illumina
  • Recent Revenue History
    • Table 15-12: Illumina Diagnostics Revenues 2017-2021 (millions $)
  • COVID-19
  • Ortho Clinical Diagnostics (Ortho)
  • Recent Revenue History
    • Table 15-13: Ortho Clinical Diagnostics Revenues 2017-2021 (millions $)
  • Blood Bank
  • Core Lab / Immunoassays
  • COVID-19
  • PerkinElmer, Inc
  • Recent Revenue History
    • Table 15-14: PerkinElmer IVD Revenues 2017-2021 (millions $)
  • Diagnostics
  • COVID-19
  • QIAGEN
  • Recent Revenue History
    • Table 15-15: QIAGEN IVD Revenues 2017-2021 (millions $)
  • Tuberculosis
  • Precision Medicine / Companion Diagnostics
  • Molecular Microbiology
  • Prenatal Testing
  • Next Generation Sequencing
  • Liquid Biopsy
  • COVID-19
  • Roche Diagnostics
  • Recent Revenue History
    • Table 15-16: Roche Diagnostics IVD Revenues 2017-2021 (millions $)
  • Hematology
  • Core Lab
  • Immunoassays
  • HIV
  • Core Molecular
  • Digital PCR
  • Diabetes Care
  • Coagulation
  • cobas Liat System - POC
  • HPV
  • Blood Bank
  • Transplant Medicine
  • Cancer Companion Testing
  • COVID-19
  • Siemens Healthineers (Siemens)
  • Recent Revenue History
    • Table 15-17: Siemens Healthineers IVD Revenues 2017-2021 (millions $)
  • Core Lab
  • Immunoassays
  • Hematology
  • Molecular
  • Acute Care - POC
  • COVID-19
  • Sysmex Corporation
  • Recent Revenue History
    • Table 15-18: Sysmex IVD Revenues 2017-20121(millions $)
  • Hematology
  • Coagulation
  • Urinalysis
  • Immunoassays
  • Flow Cytometry
  • Precision Medicine / Companion Test Diagnostics
  • Oncology
  • COVID-19
  • Thermo Fisher Scientific Inc.
  • Recent Revenue History
    • Table 15-19: Thermo Fischer IVD Revenues 2017-2021 (millions $)
  • Immunoassays
  • Microbiology
  • Next Generation Sequencing
  • qPCR
  • Mass Spectrometry
  • COVID-19
  • Werfen
  • Recent Revenue History
    • Table 15-20: Werfen IVD Revenues 2017-2021 (millions $)
  • Hematology
  • Advanced Cell Diagnostics (ACD)
  • Autoimmunity